Login to Your Account

Takeda Settling in Russia with $96M Manufacturing Facility

By Nuala Moran
Staff Writer

Wednesday, September 12, 2012

LONDON – Takeda Pharmaceutical Co Ltd. is celebrating the completion of its €75 million (US$96 million) manufacturing facility in Russia, becoming one of the first international pharmaceutical companies to put down roots in that important emerging market.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription